To create these custom components, Secant Medical implements an Integrated Product Development Process that involves close collaboration with clients from concept through commercialization and into next-generation design. “From both a process and a product perspective, medical device companies have much higher expectations related to quality,” said Dawn Porter Eringis, vice president, business development & marketing at Secant Medical. “We’ve responded to this quality emphasis through our investment in state-of-the-art analytical instrumentation and by strengthening our risk-based assessment of products. The MD&M East exhibition gives us an opportunity to share how we are moving towards having a true impact on medical technology.”
About MD&M East: A conference and exhibition held at the Jacob Javits Convention Center, MD&M East is a premier resource for the medical device industry, offering access to new technologies, world-class suppliers and expertise, updates on recent research and commercialization, and services for every aspect of the medical product development process.
About Secant Medical: Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry. We partner with clients to design, develop, and manufacture high-performance biomedical structures for applications in cardiovascular, neurovascular, orthopedic and general surgery. Built on a 70-year history, we’re committed to the future of regenerative medicine and actively engage in research partnerships to advance next-generation biomaterial technology into practical applications for the medical device and pharmaceutical industries. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or email@example.com; or visit www.secantmedical.com.